Novel combination treatment of type 2 diabetes DPP-4 inhibition + metformin
Bo AhrénDepartment of Clinical Sciences, Division of Medicine, Lund University, Lund, SwedenAbstract: Inhibition of dipeptidyl peptidase-4 (DPP-4) as a novel therapy for type 2 diabetes is based on prevention of the inactivation process of bioactive peptides, the most important in the con...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2008-04-01
|
| Series: | Vascular Health and Risk Management |
| Online Access: | https://www.dovepress.com/novel-combination-treatment-of-type-2-diabetes-dpp-4-inhibition--metfo-peer-reviewed-article-VHRM |